• / Free eNewsletters & Magazine
  • / My Account
Home>Funds>iShares Nasdaq Biotechnology

iShares Nasdaq Biotechnology

  1. All
  2. Morningstar Articles
  3. Investing
  1. Where Are the Opportunities in U.S. Health Care?

    As the sector has continued to best the broader market, a look both at the dynamics that would drive further outperformance by the sector and at funds that investors can use to tap those themes.

  2. An ETF for This Lagging Sector

    Biotech companies' returns have diverged from the broader market in recent weeks amid concerns over greater regulation and price discounting.

  3. Why the Short-Term Tumult?

    This article represents opinions of the author and not those of his firm and are subject to change from time to time and do not constitute a recommendation to purchase and sale any security nor to engage in any particular investment strategy. The information contained here has been obtained from ...

  4. Biotech ETFs: Which One Is Best Now?

    The five biotech ETFs have very different portfolios with markedly different performance.

  5. Analytical and Independent

    Jerry Slusiewicz depends on his own analysis and risk-management philosophy to keep client portfolios in order.

  6. 2008's ETF Winners

    ETFs are gathering assets amid the market malaise.

  7. Bond Investors, Undervalued ETFs, Frontier Markets, and More

    A roundup of investment news from Morningstar Advisor magazine.

  8. Five ETFs to Let Run

    It's never a good idea to sell an investment just because it's up.

  9. Tuttle Tactical Management Weekly Market Notes

    Tuttle Tactical Management, LLC is an investment adviser registered with the U.S. Securities and Exchange Commission. You should not assume that any discussion or information contained in this letter serves as the receipt of, or as a substitute for, personalized investment advice from Tuttle ...

Upcoming Events

©2014 Morningstar Advisor. All right reserved.